Food and Drug Administration

Condividi contenuti
Aggiornato: 12 ore 43 min fa

FDA Roundup: February 22, 2022

Ma, 22/02/2022 - 22:42
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

Sa, 19/02/2022 - 03:01
Today, the FDA is alerting the public that several categories of FDA-regulated products purchased from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use.
Categorie: Istituzioni

FDA Roundup: February 18, 2022

Ve, 18/02/2022 - 22:20
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Warns Consumers Not to Use Certain Powdered Infant Formula Produced in Abbott Nutrition’s Facility in Sturgis, Michigan

Ve, 18/02/2022 - 00:18
The FDA, along with the CDC and our state and local partners, is investigating complaints of Cronobacter and Salmonella illnesses related to Similac powdered infant formula.
Categorie: Istituzioni

FDA Roundup: February 15, 2022

Ma, 15/02/2022 - 22:59
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Roundup: February 11, 2022

Ve, 11/02/2022 - 22:50
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant

Ve, 11/02/2022 - 21:24
The FDA issued an emergency use authorization for a new monoclonal antibody for the treatment of COVID-19 that retains activity against the omicron variant.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Postpones Advisory Committee Meeting to Discuss Request for Authorization of Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of Age

Ve, 11/02/2022 - 20:41
The FDA is postponing the Feb. 15 Vaccines and Related Biological Products Advisory Committee meeting given new data that have recently emerged regarding Pfizer’s emergency use authorization request for the use of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months through 4 years of age.
Categorie: Istituzioni

FDA Takes Steps Aimed at Fostering Development of Non-Addictive Alternatives to Opioids for Acute Pain Management

Me, 09/02/2022 - 16:53
The U.S Food and Drug Administration issued a draft guidance to provide recommendations to companies developing non-opioid analgesics for acute pain lasting up to 30 days, typically in response to some form of tissue injury, such as trauma or surgery.
Categorie: Istituzioni

FDA Roundup: February 8, 2022

Me, 09/02/2022 - 00:10
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Roundup: February 4, 2022

Ve, 04/02/2022 - 22:02
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Sodium Reduction Efforts Underscored in USDA’s Transitional Nutrition Standards for School Meals

Ve, 04/02/2022 - 17:09
FDA Sodium Reduction Efforts Underscored in USDA’s Transitional Nutrition Standards for School Meals
Categorie: Istituzioni

FDA Approves First Generic of Restasis

Me, 02/02/2022 - 20:53
The U.S. Food and Drug Administration today approved an application for the first generic of Restasis (cyclosporine ophthalmic emulsion) eye drops to increase tear production.
Categorie: Istituzioni

FDA Approves First Generic of Restasis

Me, 02/02/2022 - 20:53
The U.S. Food and Drug Administration today approved an application for the first generic of Restasis (cyclosporine ophthalmic emulsion) eye drops to increase tear production.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Advisory Committee Meeting to Discuss Request for Authorization of Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of Age

Ma, 01/02/2022 - 23:37
FDA announced a virtual meeting of its Vaccines and Related Biological Products Advisory Committee on Feb. 15 to discuss the request for emergency use authorization of the Pfizer-BioNTech COVID-19 Vaccine for use in children 6 months through 4 years of age.
Categorie: Istituzioni

FDA Roundup: February 1, 2022

Ma, 01/02/2022 - 22:53
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Roundup: February 1, 2022

Ma, 01/02/2022 - 22:53
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine

Lu, 31/01/2022 - 18:15
The FDA approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.
Categorie: Istituzioni

FDA Roundup: January 28, 2022

Ve, 28/01/2022 - 22:51
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Roundup: January 25, 2022

Ma, 25/01/2022 - 23:12
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni